Cure
Berlin, DE · Founded 2021 · 22 employees on LinkedIn · 24 known investors
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders. The platform provides integration with point-of-sale systems, product data management, and marketing campaigns for German-speaking pharmacies.
Also known as CURE · CURE Group GmbH · GetCure
Founders & leadership
Cure was founded in 2021 by Manuel Aberle.
Investors · 24
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2023
Lerer Hippeau (lead), Great Oaks Venture Capital, Joyance Partners, Silas Capital, Simple Food Ventures, Valedor Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026CURE is a Berlin-based digital health company operating an ordering platform for pharmacies. Pharmacies that join CURE are listed on the apps of consumer delivery partners such as Lieferando and Wolt, where customers order non-prescription (freiverkäufliche) products. Orders are aggregated in a single CURE dashboard, product availability is checked automatically against the pharmacy's point-of-sale system, and couriers collect the prepared orders for delivery to the customer. CURE's service includes full integration of the pharmacy across the partner platforms, provision of the required product data, and advertising campaigns intended to increase pharmacy visibility. The company states its platform is compatible with common German pharmacy POS systems including ADG, Awinta, Lauer-Fischer, Pharmatechnik, ApoSoft and Apotechnik, requires no separate app or staff training, and is GDPR-compliant. The site claims partner pharmacies can generate up to 1,200 additional orders per month.
Earlier positioning of the company centred on a consumer health app: CURE described itself as building a single app bringing together pharmacy ordering, physician appointments, digital prescriptions and online medical consultation, with telehealth and e-prescription products listed as forthcoming. In that model, users ordered medicines through the CURE app, pharmacies packed the orders and CURE riders delivered them, with pharmacists able to advise customers by phone or in-app chat and track deliveries in a pharmacy dashboard. Press coverage described delivery fees of EUR 2.99 for immediate delivery and EUR 1.99 for scheduled delivery, and noted the business carried no warehousing or inventory costs.
The company was founded in December 2021 by Ali El-Ali (CEO) and Manuel Aberle (COO). It is registered as CURE Group GmbH and has operated a French-language site targeting pharmacies in France.
Founding story
CURE was founded in December 2021 in Berlin by Ali El-Ali (CEO) and Manuel Aberle (COO), with the stated aim of simplifying access to medical care without patients leaving home by consolidating fragmented health system services into a single app.
Business model
CURE places partner pharmacies onto third-party consumer delivery apps and handles integration, product data and marketing on their behalf. Use of the ordering platform carries no fixed fee for pharmacies; instead a per-order fee applies when a pharmacy receives an order through the platform, with no minimum contract term. In its earlier app-based model, CURE charged end users a delivery fee (EUR 2.99 immediate, EUR 1.99 scheduled) for medicines picked up from partner pharmacies by CURE riders.
Transaction-based: a per-order fee charged to partner pharmacies for orders received via the CURE platform, and previously consumer-paid delivery fees per order.
Traction
The company's website cites up to 1,200 additional orders per month per pharmacy and features testimonials from named partner pharmacies including Apotheke des Westens, Burger Apotheke and a pharmacy at Leipziger Platz.
Latest developments
CURE announced that Lieferando has integrated the CURE pharmacy platform, and markets the ordering platform to German pharmacies as compatible with all common POS systems.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Operates in the German on-demand pharmacy and prescription delivery market, which press coverage described as expanding following legislative changes enabling e-prescriptions, with roughly 750 million prescription orders a year in Germany. The company has positioned itself around recurring revenue and low burn rather than a warehouse-based rapid delivery model.
No warehousing or inventory costs; pharmacies retain their own customer relationships; integration with existing POS systems and workflows without a separate app or staff training; riders can complete more deliveries per trip because medicines are small relative to groceries.
Technology
An ordering platform integrated with pharmacy point-of-sale systems (ADG, Awinta, Lauer-Fischer, Pharmatechnik, ApoSoft, Apotechnik) so that only in-stock products can be displayed and ordered. Orders arriving from multiple demand partners are consolidated in a single management view, with in-app or dashboard communication between pharmacy and customer and delivery tracking. The company markets the platform as an AI pharmacy platform and states full GDPR compliance.
Go-to-market
Direct acquisition of partner pharmacies through an online sign-up form and consultation booking with a sales team, supported by testimonials from partner pharmacies and press visibility. Demand is sourced through partnerships with established delivery marketplaces (Lieferando, Wolt) rather than requiring pharmacies to build their own audience. In the earlier consumer model the company supplied partner pharmacies with marketing material and a tablet for order management.
Independent pharmacies in Germany (and, in an earlier phase, France) seeking online sales channels; end consumers ordering over-the-counter medicines and, in the app model, prescriptions and telehealth services.
Geography
Headquartered in Berlin, Germany, with German-language operations aimed at pharmacies across all German federal states, a French-language site for pharmacies in France, and a partner sign-up form covering a range of European countries.
History
After its founding in December 2021, CURE raised a $4.6 million seed investment from Craft Ventures in January 2022 and a $15 million (EUR 15 million) Series A led by Breega in September 2022, which it earmarked for product development, deeper expansion in major German cities, entry into France, and additional platform features including online consultation, telediagnostics and telemonitoring. The company later shifted its public positioning toward a B2B ordering platform that lists pharmacies on third-party delivery marketplaces, announcing an integration with Lieferando.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlap
Companies competing with Cure for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 4
launches, deals, and filingsThe company's website announces that delivery platform Lieferando has integrated CURE's pharmacy platform; customers order over-the-counter products through partner apps such as Lieferando and Wolt.
Berlin-based pharmacy delivery startup CURE raised a Series A led by French VC Breega, with Abstract Ventures, J12 Ventures and PiLabs participating. Funds earmarked for product development, expansion in German cities and entry into France.
$15M source ↗
Following the Series A, CURE stated it would open its first international location in France and expand within Germany; the company operates a French-language site for pharmacies.
$4.6M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
Highlights from the 2026 Cultivating a Cure – Ohio Ag Net | Ohio's Country Journalocj.com · Aug 2026▸Research sources · 8
primary sources listed
- Curegetcure.app · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Cure do?
- Berlin-based CURE connects pharmacies with delivery platforms such as Lieferando and Wolt to generate online orders.
- Who founded Cure?
- Cure was founded by Manuel Aberle in 2021.
- Who are Cure's investors?
- Cure's investors include Abstract Ventures, Artis Ventures, J12 Ventures, Accomplice, Catalyst Health Ventures, Cosmic Venture Partners, FELIX CAPITAL, Genoa Ventures and 14 more.
- Where is Cure headquartered?
- Cure is headquartered in Berlin, DE.